1. Home
  2. SG vs IBRX Comparison

SG vs IBRX Comparison

Compare SG & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SG
  • IBRX
  • Stock Information
  • Founded
  • SG 2007
  • IBRX 2014
  • Country
  • SG United States
  • IBRX United States
  • Employees
  • SG N/A
  • IBRX N/A
  • Industry
  • SG Restaurants
  • IBRX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SG Consumer Discretionary
  • IBRX Health Care
  • Exchange
  • SG Nasdaq
  • IBRX Nasdaq
  • Market Cap
  • SG 2.5B
  • IBRX 2.4B
  • IPO Year
  • SG 2021
  • IBRX N/A
  • Fundamental
  • Price
  • SG $15.22
  • IBRX $2.07
  • Analyst Decision
  • SG Buy
  • IBRX Strong Buy
  • Analyst Count
  • SG 13
  • IBRX 5
  • Target Price
  • SG $29.67
  • IBRX $11.35
  • AVG Volume (30 Days)
  • SG 4.9M
  • IBRX 8.6M
  • Earning Date
  • SG 05-08-2025
  • IBRX 05-16-2025
  • Dividend Yield
  • SG N/A
  • IBRX N/A
  • EPS Growth
  • SG N/A
  • IBRX N/A
  • EPS
  • SG N/A
  • IBRX N/A
  • Revenue
  • SG $685,280,000.00
  • IBRX $14,745,000.00
  • Revenue This Year
  • SG $16.58
  • IBRX $579.28
  • Revenue Next Year
  • SG $20.85
  • IBRX $179.96
  • P/E Ratio
  • SG N/A
  • IBRX N/A
  • Revenue Growth
  • SG 11.10
  • IBRX 2270.58
  • 52 Week Low
  • SG $16.29
  • IBRX $1.83
  • 52 Week High
  • SG $45.12
  • IBRX $9.16
  • Technical
  • Relative Strength Index (RSI)
  • SG 30.00
  • IBRX 36.78
  • Support Level
  • SG $18.12
  • IBRX $1.83
  • Resistance Level
  • SG $18.63
  • IBRX $2.63
  • Average True Range (ATR)
  • SG 1.09
  • IBRX 0.19
  • MACD
  • SG -0.11
  • IBRX -0.05
  • Stochastic Oscillator
  • SG 9.49
  • IBRX 23.08

About SG Sweetgreen Inc.

Sweetgreen Inc is a mission-driven, next-generation restaurant and lifestyle brand that serves healthy food at scale. Its bold vision is to be as ubiquitous as traditional fast food, but with the transparency and quality that consumers increasingly expect. It is creating plant-forward, seasonal, and earth-friendly meals from fresh ingredients and produce that prioritizes organic, regenerative, and local sourcing.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

Share on Social Networks: